Ligand-gated ion channels open when bound by neurotransmitters, allowing rapid (millisecond) ion flux. Examples include nicotinic acetylcholine receptors, AMPA and NMDA glutamate receptors, and GABAA receptors. These channels have two linked functions: ligand binding and gate opening, often with allosteric modulation sites.
Measure synaptic currents using voltage clamp. Fit activation/deactivation kinetics to exponentials.
All receptors open when their ligand binds—binding doesn't guarantee opening. All channels pass cations—some selectively pass anions.
From your study of synaptic transmission, you know that chemical signaling across a synapse involves neurotransmitter release, diffusion across the cleft, and receptor binding on the postsynaptic membrane. Ligand-gated ion channels (also called ionotropic receptors) are the fastest mechanism for converting that chemical signal back into an electrical one. They are membrane proteins that combine two functions in a single molecule: a binding site for a neurotransmitter (the ligand) and a gated pore that allows specific ions to cross the membrane. When the neurotransmitter binds, the protein changes shape and the pore opens — typically within microseconds to milliseconds, far faster than any second-messenger cascade.
The ions that flow through the open channel determine whether the effect is excitatory or inhibitory. Recall from your understanding of resting membrane potential that the inside of a neuron sits around -70 mV, maintained by the unequal distribution of ions. Channels that pass cations (sodium, potassium, calcium) generally depolarize the membrane toward threshold, producing an excitatory postsynaptic potential (EPSP). The nicotinic acetylcholine receptor at the neuromuscular junction is the classic example: acetylcholine binds, sodium rushes in, and the muscle fiber depolarizes toward contraction. Similarly, AMPA and NMDA glutamate receptors pass cations to mediate excitation in the brain. Channels that selectively pass chloride anions, like the GABA_A receptor, drive the membrane potential more negative (or clamp it near rest), producing an inhibitory postsynaptic potential (IPSP) that opposes firing.
A key structural feature of these channels is allosteric modulation — the presence of binding sites distinct from the neurotransmitter site that can enhance or reduce channel function. The GABA_A receptor is the most pharmacologically exploited example: benzodiazepines (like diazepam) bind their own site on the receptor and increase the frequency of channel opening when GABA is present, amplifying inhibition without directly activating the channel. Barbiturates bind yet another site and increase the duration of opening. Alcohol acts at a similar modulatory site. None of these drugs are the channel's natural ligand — they modify how the channel responds to GABA. This principle of allosteric modulation explains why so many neurological and psychiatric drugs target ligand-gated channels: you can fine-tune synaptic transmission without replacing the neurotransmitter itself.
It is important to understand what ligand-gated channels do *not* do. Binding does not guarantee opening — channels flicker between open and closed states probabilistically, and ligand binding shifts the probability rather than acting as a simple on/off switch. Also, these channels desensitize: prolonged exposure to neurotransmitter causes the channel to enter a closed, unresponsive conformation even with ligand still bound. Desensitization prevents overstimulation and shapes the time course of synaptic responses. The combination of rapid gating, ion selectivity, allosteric modulation, and desensitization makes ligand-gated ion channels precisely tuned molecular machines at the heart of fast synaptic communication.